Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 4/20 | 0.52 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 7/20 | 0.47 |
| ▸ | NPY1R | P25929 | 4/20 | 0.47 |
| ▸ | NPY2R | P49146 | 3/20 | 0.47 |
| ▸ | F10 | P00742 | 3/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.45 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7117030 | 0.91 | KCNA5 (0.49) | NPY5RKCNA5NPY4RNPY1RNPY2R | |
| SCHEMBL2922269 | 0.89 | NPY4R (0.47) | NPY5RNPY4RNPY1RNPY2RKISS1R | |
| SCHEMBL2926943 | 0.88 | ITGB3 (0.51) | NPY5RNPY4RNPY1RNPY2RKISS1R | |
| SCHEMBL3298844 | 0.87 | F2 (0.52) | NPY5RF10F2 | |
| SCHEMBL2927716 | 0.87 | KCNA5 (0.49) | NPY5RKCNA5MMP1MMP2MMP9 | |
| SCHEMBL2924336 | 0.87 | KCNA5 (0.55) | NPY5RKCNA5MMP1MMP2MMP9 | |
| SCHEMBL2924338 | 0.87 | KCNA5 (0.55) | NPY5RKCNA5MMP1MMP2MMP9 | |
| SCHEMBL7534730 | 0.87 | BMP1 (0.51) | NPY5RMMP2MMP9NPY4RNPY1R | |
| SCHEMBL6551505 | 0.86 | MMP1 (0.44) | NPY5RKCNA5MMP1MMP2MMP9 | |
| SCHEMBL2928771 | 0.85 | F2 (0.53) | NPY5RNPY4RNPY1RNPY2RF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678196-B1 | SULFONYLAMINO-PEPTIDOMIMETICS ACTIVE ON THE SOMATOSTATIN RECEPTOR SUBTYPES 4 (SSTR4) AND 1 (SSTR1) | WURSTER SIEGFRIED (FI) | 2008-08-13 | — | — | EP | disclosed |
| US-20070129313-A1 | Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) | SIEGFRIED WURSTER (FI) | 2007-06-07 | — | — | US | disclosed |
| EP-1678196-A1 | SULFONYLAMINO-PEPTIDOMIMETICS ACTIVE ON THE SOMATOSTATIN RECEPTOR SUBTYPES 4 (SSTR4) AND 1 (SSTR1) | Oy Juvantia Pharma Ltd (FI) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005033124-A1 | SULFONYLAMINO-PEPTIDOMIMETICS ACTIVE ON THE SOMATOSTATIN RECEPTOR SUBTYPES 4 (SSTR4) AND 1 (SSTR1) | OY JUVANTIA PHARMA LTD (FI) | 2005-04-14 | — | — | WO | disclosed |
| US-20030144310-A1 | Molecules specific for NPFF receptors and uses thereof | H. LUNDBECK A/S (DK) | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129313-A1 | Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) | SSTR4, SSTR1, SSTR3 | NPY5R 25/4885KCNA5 842/4885MMP1 4273/4885 |
| US-20030144310-A1 | Molecules specific for NPFF receptors and uses thereof | NPFFR1, NPFFR2, NPBWR1 | NPY5R 372/4885KCNA5 2605/4885MMP1 4557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.